213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells
Creators
- 1. Department of Otolaryngology Head and Neck Surgery, Technische Universität München, Munich (Germany)
- 2. Department of Nuclear Medicine, Technische Universität München, Munich (Germany)
- 3. Department of Radiotherapy, Technische Universität München, Munich (Germany)
- 4. Department of Gynecology and Obstetrics University of Regensburg, Regensburg (Germany)
- 5. Institute for Transuranium Elements, European Commission, Joint Research Centre, Karlsruhe (Germany)
Description
Introduction: Treatment of patients with squamous cell carcinoma of head and neck is hampered by resistance of tumor cells to irradiation. Additional therapies enhancing the effect of X-ray irradiation may be beneficial. Antibodies targeting EGFR have been shown to improve the efficacy of radiation therapy. Therefore, we analyzed cytotoxicity of 213Bi-anti-EGFR immunoconjugates in combination with X-ray irradiation. Methods: The monoclonal anti-EGFR antibody matuzumab was coupled to CHX-A"-DTPA forming stable complexes with 213Bi. Cytotoxicity of X-ray radiation, of treatment with 213Bi-anti-EGFR monoclonal antibodies (MAb) or of a combined treatment regimen was assayed using cell proliferation and colony formation assays in UD-SCC5 cells. Key proteins of cell-cycle arrest and cell death were examined by Western blot analysis. Cell cycle analysis was performed by flow cytometry. DNA double-strand breaks were detected via γH2AX and quantified using Definiens™ software. Results: Irradiation with X-rays or treatment with 213Bi-anti-EGFR-MAb resulted in median lethal dose (LD50) values of 12 Gy or 130 kBq/mL, respectively. Treatment with 37 kBq/mL of 213Bi-anti-EGFR-MAb or 2 Gy of X-rays had only little effect on colony formation of UD-SCC5 cells. In contrast, a combined treatment regimen (37 kBq/mL plus 2 Gy) significantly decreased colony formation and enhanced the formation of DNA double-strand breaks. As revealed by flow cytometry, radiation treatments caused accumulation of cells in the G0/G1 phase. Both treatment with 213Bi-anti-EGFR immunoconjugates and application of the combined treatment regimen triggered activation of genes of signaling pathways involved in cell-cycle arrest and induction of apoptosis like p21/Waf, GADD45, Puma and Bax, which were only marginally modulated by X-ray irradiation of cells. Conclusions: 213Bi-anti-EGFR-MAb enhances cytotoxicity of X-ray irradiation in UD-SCC5 cells most probably due to effective induction of DNA double-strand breaks. Induction of genes involved in cell-cycle arrest and cell death is almost exclusively due to 213Bi-anti-EGFR-MAb and seems to be independent of p53 function
Availability note (English)
Available from http://dx.doi.org/10.1016/j.nucmedbio.2013.09.010Additional details
Identifiers
- DOI
- 10.1016/j.nucmedbio.2013.09.010;
- PII
- S0969-8051(13)00209-6;
Publishing Information
- Journal Title
- Nuclear Medicine and Biology
- Journal Volume
- 41
- Journal Issue
- 1
- Journal Page Range
- p. 68-76
- ISSN
- 0969-8051
- CODEN
- NMBIEO
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45088160
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- APOPTOSIS; BISMUTH 213; CARCINOMAS; CELL CYCLE; CELL PROLIFERATION; COLONY FORMATION; COMPUTER CODES; DNA; DTPA; GENES; HEAD; IRRADIATION; LETHAL DOSES; MONOCLINIC LATTICES; MONOCLONAL ANTIBODIES; NECK; PROTEINS; RADIOIMMUNOTHERAPY; STRAND BREAKS; TOXICITY; TUMOR CELLS; X RADIATION
- Descriptors DEC
- ALPHA DECAY RADIOISOTOPES; AMINO ACIDS; ANIMAL CELLS; ANTIBODIES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BISMUTH ISOTOPES; BODY; CARBOXYLIC ACIDS; CHELATING AGENTS; CRYSTAL LATTICES; CRYSTAL STRUCTURE; DISEASES; DNA DAMAGES; DOSES; DRUGS; ELECTROMAGNETIC RADIATION; HEAVY NUCLEI; IMMUNOTHERAPY; IONIZING RADIATIONS; ISOTOPES; MEDICINE; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; NUCLEIC ACIDS; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; RADIATIONS; RADIOISOTOPES; RADIOLOGY; RADIOPROTECTIVE SUBSTANCES; RADIOTHERAPY; RESPONSE MODIFYING FACTORS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.